Recurrence of primary sclerosing cholangitis following liver transplantation

Hepatology

Volumn 29, Issue 4, 1999, Pages 1050-1056

  Graziadei, Ivo W ^a   Wiesner, Russell H ^a   Batts, Kenneth P ^a   Marotta, Paul J ^a   Larusso, Nicholas F ^a   Porayko, Michael K ^a   Eileen Hay, J ^a   Gores, Gregory J ^a   Charlton, Michael R ^a   Ludwig, Jurgen ^a   Poterucha, John J ^a   Steers, Jeffery L ^a   Krom, Ruud A F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGIOGRAPHY; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; INCIDENCE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; ROUX Y ANASTOMOSIS; TREATMENT OUTCOME;

EID: 0032920146     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290427     Document Type: Article

References (28)

1. Wiesner RH, Porayko MK, LaRusso NF, Ludwig J. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, eds. Disease of the liver. Vol 1. 7th ed. Philadelphia: Lippincott 1993:411-426.
2. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-33.
3. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ. Primary sclerosing cholangilis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-877.
4. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994;69:969-982.
5. McEntee G, Wiesner RH, Rosen C, Cooper J, Wahlstrom E. A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. Transpl Proc 1991; 23:1563-1564.
6. Narumi S, Roberts JP, Emond JC, Lake J, Asher NL. Liver transplantation for sclerosing cholangitis. HEPATOLOGY 1995;22:451-457.
7. Wiesner RH, Porayko MK, Hay JE, LaRusso NF, Steers JL, Krom RAF, Dickson ER. Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Liver Transpl Surg 1996;2(Suppl 1):99S-108S.
8. Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, et al. Orthotopic liver transplantation for primary sclerosing cholangitis: A 12-year single center experience. Ann Surg 1997;225:472-483.
9. Chapman RW, Jewell DP. Primary sclerosing cholangitis-an immunologically mediated disease? West J Med 1985;143:193-195.
10. Crippin JS, Lindor KD. Primary sclerosing cholangitis: etiology and immunology. Eur J Gastroenterol Hepatol 1992;1992;4:261-265.
11. Letourneau JG, Day DL, Hunter DW, Ascher NL, Najarian JS, Thompson WM, Castaneda-Zuniga WR. Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis. Radiology 1988;167:349-351.
12. Sheng R, Zaajko AB, Campbell WL, Abu-Elmagd KM. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. AJR 1993;161:297-300.
13. Campbell WL, Sheng R, Zajko AB, Abu-Elmagd KM, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology 1994;191:735-740.
14. Sheng R, Campbell WL, Zajko AB, Baron RL. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR 1996;166:1109-1113.
15. Boyer TD. Does primary sclerosing cholangitis recur after liver transplant? No! Liver Transpl Surg 1997;3(Suppl 1):24S-25S.
16. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis. HEPATOLOGY 1994;20:356-361.
17. Krom RAF, Wiesner RH, Rettke SR, Ludwig J, Southern PA, Hermans PE, Taswell HF. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989;64:84-94.
18. Ludwig J. Classification and terminology of hepatic allograft rejection: wither bound? Mayo Clin Proc 1989;64:676-679.
19. Fuller TC, Phelan D, Gebel HM, Rodey GE. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation 1982;34:24-29.
20. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, Wiesner RH, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after transplantation. HEPATOLOGY 1993;17:605-609.
21. Terblanche J, Allison HF, Northover JMA. An ischemic basis for biliary strictures. Surgery 1983;94:52-57.
22. Zajko AB, Campbell WL, Logsdon GA, Bron KM, Tzakis A, Esquivel CO, Starzl TE. Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR 1987;149:485-489.
23. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RAE The acute vanishing bile duct syndrome (acute reversible rejection) after orthotopic liver transplantation. HEPATOLOGY 1987;7:476-483.
24. Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanism of bile duct loss: direct immunologic and ischemic factors. HEPATOLOGY 1989;9:204-209.
25. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE, Moore SB, Wiesner RH, Krom RAE Ischemic-type biliary complications after orthotopic liver transplantation. HEPATOLOGY 1992;16:49-53.
26. Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991;11:11-17.
27. Starzl TE, Demetris AJ. Perioperative immune events. In: Starzl TE, Demetris AJ (eds). Liver Transplantation. Mosby-Year Book Medical Publishers, Chicago, IL, 1990:57-70.
28. Sherlock S. Pathogenesis of sclerosing cholangitis: the role of nonimmune factors. Semin Liver Dis 1991;11:5-10.